01/08/2024  10:08:21 Var. -0.570 Volume Denaro10:12:22 Lettera10:12:22 Capitalizzazione di mercato Dividend Y. Rapporto P/E
69.980EUR -0.81% 120
Fatturato: 8,402.600
69.780Quantità in denaro: 600 70.420Quantità in lettera: 600 87.52 bill.EUR - -

Descrizione business

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Daniel O’Day
Consiglio di amministrazione
Andrew Dickinson, Jyoti Mehra, Stacey Ma, Flavius Martin, Johanna Mercier, Cindy Perettie, Deborah H. Telman, Merdad Parsey
Consiglio di sorveglianza
Daniel O’Day, Jacqueline K. Barton, Jeffrey A. Bluestone, Sandra J. Horning, Kelly A. Kramer, Harish Manwani, Anthony Welters, Ted W. Love, Javier J. Rodriguez
 

Dati aziendali

Name: Gilead Sciences Inc.
Indirizzo: 333 Lakeside Drive,Foster City, California 94404, USA
Telefono: +1-650-574-3000
Fax: +1-650-578-9264
E-mail: corporate_developmen...ad.com corporate_development@gilead.com
Internet: www.gilead.com
Industria: Healthcare
Settore: Pharmaceutical Industry
Sub settore: Pharmaceuticals
Fine dell'anno finanziario: 31/12
Flottante libero: 99.89%
Data dell'IPO: 22/01/1992

Rapporti con gli investitori

Name: Jacquie Ross
IR telefono: +1-650-524-7792
IR Fax: -
IR e-mail: investor_relations@gilead.com

Company calendar

CW 32 | 08/08/2024 Interim Report 2nd Quarter/6 Months
 

Principali azionisti

Altri
 
55.91%
BlackRock Inc.
 
9.86%
Vanguard Group
 
8.98%
Capital World Investors
 
6.69%
CAPITAL RESEARCH GLOBAL INVESTOR
 
4.79%
State Street Corporation
 
4.78%
Dodge & Cox
 
2.67%
GEODE CAPITAL MANAGEMENT LLC
 
2.03%
Wellington Management Group
 
1.50%
Altri
 
2.80%